(Q39798969)

14 September 2017

title

CpG ODN enhances the efficacy of rituximab in non-Hodgkin lymphoma (English)

1 reference

14 September 2017

1 reference

3

Pierre Youinou

1 reference

14 September 2017

Virginie Buhé

1

1 reference

14 September 2017

Thomas Guerrier

series ordinal

2

1 reference

14 September 2017

Christian Berthou

series ordinal

4

1 reference

14 September 2017

Séverine Loisel

series ordinal

5

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

Annals of the New York Academy of Sciences

14 September 2017

published in

1 reference

14 September 2017

volume

1173

1 reference

14 September 2017

page(s)

858-864

1 reference

Toll like receptors and autoimmunity: a critical appraisal

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2009.04615.X

Mechanism and function of a newly identified CpG DNA motif in human primary B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2009.04615.X

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2009.04615.X

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2009.04615.X

10.1111/J.1749-6632.2009.04615.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference